Nutrien (NYSE:NTR - Get Free Report)'s stock had its "sector perform" rating reissued by stock analysts at Scotiabank in a note issued to investors on Wednesday, MarketBeat.com reports. They presently have a $62.00 price objective on the stock. Scotiabank's price target indicates a potential upside of 7.13% from the stock's current price.
Several other equities analysts have also issued reports on the company. TD Securities lifted their price target on Nutrien from $64.00 to $67.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Oppenheimer raised their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an "outperform" rating in a report on Tuesday, May 13th. Berenberg Bank raised their target price on shares of Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a report on Tuesday, April 15th. BNP Paribas upgraded Nutrien to a "strong-buy" rating in a research note on Wednesday, April 9th. Finally, Royal Bank of Canada boosted their price target on Nutrien from $60.00 to $65.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Two research analysts have rated the stock with a sell rating, six have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $61.44.
Read Our Latest Stock Report on Nutrien
Nutrien Stock Down 0.1%
NTR traded down $0.03 during trading on Wednesday, reaching $57.87. The stock had a trading volume of 484,838 shares, compared to its average volume of 2,414,208. The stock's 50 day moving average is $52.62 and its two-hundred day moving average is $50.30. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $28.26 billion, a price-to-earnings ratio of 42.25, a P/E/G ratio of 1.19 and a beta of 0.79. Nutrien has a one year low of $43.69 and a one year high of $60.87.
Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.35 by ($0.24). The business had revenue of $4.67 billion during the quarter, compared to analysts' expectations of $5.16 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. Nutrien's revenue for the quarter was down 5.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.46 EPS. As a group, analysts expect that Nutrien will post 3.72 earnings per share for the current year.
Institutional Trading of Nutrien
A number of institutional investors have recently bought and sold shares of NTR. Fairway Wealth LLC purchased a new stake in Nutrien in the fourth quarter worth $27,000. HHM Wealth Advisors LLC lifted its holdings in Nutrien by 331.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock valued at $28,000 after buying an additional 480 shares in the last quarter. Assetmark Inc. lifted its holdings in Nutrien by 1,437.5% during the 4th quarter. Assetmark Inc. now owns 738 shares of the company's stock valued at $33,000 after buying an additional 690 shares in the last quarter. Asset Planning Inc bought a new stake in Nutrien during the 4th quarter valued at about $35,000. Finally, Harbour Investments Inc. lifted its holdings in Nutrien by 94.8% during the 1st quarter. Harbour Investments Inc. now owns 715 shares of the company's stock valued at $35,000 after buying an additional 348 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.
Nutrien Company Profile
(
Get Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Recommended Stories

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.